Growth hormone (GH) resistance - characterized by GH hypersecretion, and low serum levels of growth hormone binding protein, insulin-like growth factor I (IGF-I), and insulin-like growth factor binding-protein 3 (IGF-BP3) - has also been related to growth failure in AN patients. This evidence concerns the gene IGF1 and Growth delay.